Crinetics Pharmaceuticals, Inc. (CRNX) Net margin 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) net profit margin by fiscal year — reported net income divided by reported revenue.
-6046.0%FY2025 · since FY2016: -1021.9% → -6046.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6046.0% | +22673.9 pp |
| FY2024 | -28719.9% | -23374.8 pp |
| FY2023 | -5345.1% | — |
| FY2020 | -103960.6% | -99734.1 pp |
| FY2019 | -4226.5% | -3109.7 pp |
| FY2018 | -1116.8% | -669.0 pp |
| FY2017 | -447.8% | +574.1 pp |
| FY2016 | -1021.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice